Liver cirrhosis can reduce insulin extraction, coupled with portal-systemic shunts, and leads to systemic hyperinsulinemia and insulin resistance (Elkrief et al., 2016; Garcia-Compean et al., 2009). The gene discussed is INS; the disease is hyperinsulinism.